OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review
Su Zheng, Yueping Zeng
Dermatology (2023) Vol. 239, Iss. 4, pp. 646-657
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 18

Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: A case report
Katrina Cirone, Fiona Lovegrove
SAGE Open Medical Case Reports (2025) Vol. 13
Open Access | Times Cited: 1

Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options
Carlo Alberto Maronese, Mario Valenti, Chiara Moltrasio, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2364-2376
Closed Access | Times Cited: 9

Dupilumab in real-life settings: a review of adverse events and their pathogenesis
Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pitá, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 4, pp. 439-447
Open Access | Times Cited: 5

Efficacy of Janus kinase inhibitors in the treatment of psoriasiform atopic dermatitis
Maddalena Napolitano, L. Foggia, Cataldo Patruno, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 10, pp. 1232-1234
Open Access | Times Cited: 4

Case report: Dupilumab-induced linear psoriasis: a rare presentation
Wen Sun, Kai Wang, Yunqing Ren, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access

Positionspapier Dupilumab und Impfen
Sebastian M. Schmidt, Tobias Ankermann, Carl‐Peter Bauer, et al.
Allergo Journal (2025) Vol. 34, Iss. 1, pp. 26-35
Closed Access

Adverse Effects of Dupilumab in a Child with Atopic Dermatitis: A Case Report of Anaphylaxis and Literature Review
Jing Zhang, Zhouxian Pan, Shuang Zhao, et al.
Allergy medicine. (2025), pp. 100035-100035
Open Access

The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases
Liuting Zeng, Xiang Wang, Wei Xiao, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access

Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review
Lu Lu, Jindi Feng, Shiyu Zhang, et al.
The Journal of Dermatology (2025)
Closed Access

Systemtherapie der Neurodermitis und Psoriasis im Kindes- und Jugendalter
Michael Sticherling
Deleted Journal (2025)
Closed Access

Exploring the Potential of IL-4 and IL-13 Plasma Levels as Biomarkers in Atopic Dermatitis
George Mitroi, Elena Leocadia Pleșea, George F. Mitroi, et al.
Life (2024) Vol. 14, Iss. 3, pp. 352-352
Open Access | Times Cited: 3

Paradoxical psoriasis after dupilumab treatment of prurigo nodularis treated with adalimumab
Jennifer Astrup Sørensen, Cæcilie Bachdal Johansen, Alexander Egeberg, et al.
JAAD Case Reports (2024) Vol. 52, pp. 146-149
Open Access | Times Cited: 2

Dupilumab-Induced Follicular Psoriasis and Hypercytokinemia
Yuzhu Jiao, Lichen Li, Anqi Zhao, et al.
Dermatitis (2024) Vol. 35, Iss. 6, pp. 668-670
Closed Access | Times Cited: 1

Paradoxical Psoriasis
Mariam Abdelghaffar, Sita Kottilil, Michael J. Murphy, et al.
Dermatologic Clinics (2024) Vol. 42, Iss. 3, pp. 471-480
Closed Access | Times Cited: 1

Cytotoxic and Immunomodulatory Effects of Hypericin as a Photosensitizer in Photodynamic Therapy Used on Skin Cell Cultures
Magdalena Krupka, Andrzej Bożek, Zenon Czuba, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 696-696
Open Access | Times Cited: 1

Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions
Lichen Li, Dean J. Naisbitt, Yonghu Sun, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 12, pp. 973-983
Open Access | Times Cited: 1

Position paper dupilumab and vaccination
Sebastian M. Schmidt, Tobias Ankermann, Carl‐Peter Bauer, et al.
Allergo Journal International (2024)
Open Access | Times Cited: 1

Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study
Xiyuan Zhou, Ge Yang, Xuejun Chen, et al.
Drugs & Aging (2023) Vol. 40, Iss. 10, pp. 933-940
Open Access | Times Cited: 3

Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis
Juliane Haertlé, Petra Kienlin, Gabriele Begemann, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2

Exacerbation of clinical manifestations of bullous pemphigoid after treatment with dupilumab
Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, et al.
Clinical and Experimental Dermatology (2023) Vol. 49, Iss. 4, pp. 399-400
Closed Access | Times Cited: 2

Dupilumab‐induced psoriasiform dermatitis in two pediatric cardiac transplant patients
Trevor Lockard, Sarah A. Mullen, Erica B. Lee, et al.
Pediatric Dermatology (2023) Vol. 41, Iss. 3, pp. 508-511
Open Access | Times Cited: 2

Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
Lina Weiss, Corinne Punsap Marbet, Lorenzo Barino Branca, et al.
Case Reports in Dermatology (2024) Vol. 16, Iss. 1, pp. 144-148
Open Access

Non-invasive epidermal proteome assessment-based diagnosis and molecular subclassification of psoriasis and eczematous dermatitis
Michael J. Murphy, Gloria Chen, Princess Edemobi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Pathogenetic role of IL-4 and IL-13 in atopic dermatitis: The inhibitory pathways
D. Sh. Macharadze
Medical Immunology (Russia) (2024) Vol. 27, Iss. 2, pp. 287-296
Open Access

Page 1 - Next Page

Scroll to top